These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33466780)

  • 1. Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in
    Imbrici P; Accogli A; Blunck R; Altamura C; Iacomino M; D'adamo MC; Allegri A; Pedemonte M; Brolatti N; Vari S; Cataldi M; Capra V; Gustincich S; Zara F; Desaphy JF; Fiorillo C
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33466780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions.
    Imbrici P; Altamura C; Gualandi F; Mangiatordi GF; Neri M; De Maria G; Ferlini A; Padovani A; D'Adamo MC; Nicolotti O; Pessia M; Conte D; Filosto M; Desaphy JF
    Mol Cell Neurosci; 2017 Sep; 83():6-12. PubMed ID: 28666963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
    Ishida S; Sakamoto Y; Nishio T; Baulac S; Kuwamura M; Ohno Y; Takizawa A; Kaneko S; Serikawa T; Mashimo T
    Brain Res; 2012 Jan; 1435():154-66. PubMed ID: 22206926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.
    Yuan H; Yuan H; Wang Q; Ye W; Yao R; Xu W; Liu Y
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1434. PubMed ID: 32705822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Spectrum of
    Paulhus K; Ammerman L; Glasscock E
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene.
    D'Adamo MC; Gallenmüller C; Servettini I; Hartl E; Tucker SJ; Arning L; Biskup S; Grottesi A; Guglielmi L; Imbrici P; Bernasconi P; Di Giovanni G; Franciolini F; Catacuzzeno L; Pessia M; Klopstock T
    Front Physiol; 2014; 5():525. PubMed ID: 25642194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia.
    Dinoi G; Morin M; Conte E; Mor Shaked H; Coppola MA; D'Adamo MC; Elpeleg O; Liantonio A; Hartmann I; De Luca A; Blunck R; Russo A; Imbrici P
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia.
    van der Wijst J; Konrad M; Verkaart SAJ; Tkaczyk M; Latta F; Altmüller J; Thiele H; Beck B; Schlingmann KP; de Baaij JHF
    Nephron; 2018; 139(4):359-366. PubMed ID: 29791908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in
    Lauxmann S; Sonnenberg L; Koch NA; Bosselmann C; Winter N; Schwarz N; Wuttke TV; Hedrich UBS; Liu Y; Lerche H; Benda J; Kegele J
    Front Neurol; 2021; 12():703970. PubMed ID: 34566847
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel Genetic Variants Expand the Functional, Molecular, and Pathological Diversity of
    Paulhus K; Glasscock E
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants.
    Rogers A; Golumbek P; Cellini E; Doccini V; Guerrini R; Wallgren-Pettersson C; Thuresson AC; Gurnett CA
    Am J Med Genet A; 2018 Aug; 176(8):1748-1752. PubMed ID: 30055040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.
    Tristán-Clavijo E; Scholl FG; Macaya A; Iglesias G; Rojas AM; Lucas M; Castellano A; Martinez-Mir A
    Mov Disord; 2016 Nov; 31(11):1743-1748. PubMed ID: 27477325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a New
    Karalok ZS; Megaro A; Cenciarini M; Guven A; Hasan SM; Taskin BD; Imbrici P; Ceylaner S; Pessia M; D'Adamo MC
    Front Neurol; 2018; 9():587. PubMed ID: 30140249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both gain- and loss-of-function variants of KCNA1 are associated with paroxysmal kinesigenic dyskinesia.
    Sun WB; Fu JX; Chen YL; Li HF; Wu ZY; Chen DF
    J Genet Genomics; 2024 Aug; 51(8):801-810. PubMed ID: 38570113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
    Manville RW; Abbott GW
    J Pharmacol Exp Ther; 2020 Jun; 373(3):391-401. PubMed ID: 32217768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.
    Imbrici P; D'Adamo MC; Kullmann DM; Pessia M
    Eur J Neurosci; 2006 Dec; 24(11):3073-83. PubMed ID: 17156368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia.
    Kinali M; Jungbluth H; Eunson LH; Sewry CA; Manzur AY; Mercuri E; Hanna MG; Muntoni F
    Neuromuscul Disord; 2004 Oct; 14(10):689-93. PubMed ID: 15351427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.
    Eunson LH; Rea R; Zuberi SM; Youroukos S; Panayiotopoulos CP; Liguori R; Avoni P; McWilliam RC; Stephenson JB; Hanna MG; Kullmann DM; Spauschus A
    Ann Neurol; 2000 Oct; 48(4):647-56. PubMed ID: 11026449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.
    Mestre TA; Manole A; MacDonald H; Riazi S; Kraeva N; Hanna MG; Lang AE; Männikkö R; Yoon G
    Neurogenetics; 2016 Oct; 17(4):245-249. PubMed ID: 27271339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations.
    Brownstein CA; Beggs AH; Rodan L; Shi J; Towne MC; Pelletier R; Cao S; Rosenberg PA; Urion DK; Picker J; Tan WH; Agrawal PB
    Neurogenetics; 2016 Jan; 17(1):11-6. PubMed ID: 26395884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.